Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients

por Cano, Jordi, Zorio, Esther, Mazzanti, Andrea, Arnau, Miguel Ángel, Trenor, Beatriz, Priori, Silvia G., Saiz, Javier, Romero, Lucia
Publicado 2020

Cardiac Allograft Rejection Induces Changes in Nucleocytoplasmic Transport: RANGAP1 as a Potential Non-Invasive Biomarker

por Lozano-Edo, Silvia, Roselló-Lletí, Esther, Sánchez-Lázaro, Ignacio, Tarazón, Estefanía, Portolés, Manuel, Ezzitouny, Maryem, Lopez-Vilella, Raquel, Arnau, Miguel Angel, Almenar, Luis, Martínez-Dolz, Luis
Publicado 2022